Feasibility of a Deep-inspiration Breath-hold [F]AlF-NOTA-LM3 PET/CT Imaging on Upper-abdominal Lesions in NET Patients: in Comparison with Respiratory-gated PET/CT

Overview

Journal EJNMMI Phys

Specialty Radiology

Date 2024 Aug 29

PMID 39207609

Authors

Haiqiong Zhang

Meixi Liu

Ximin Shi

Jiangyu Ma

Chao Ren

Zhenghai Huang

Ying Wang

Hongli Jing

Li Huo

Affiliations

Soon will be listed here.

Abstract

Purposes: To explore the clinical feasibility and efficacy of a deep inspiration breath-hold (BH) PET/CT using [F]AlF-NOTA-LM3 on upper abdominal lesions in patients with neuroendocrine tumors (NETs).

Methods: Twenty-three patients underwent a free-breath (FB) whole-body PET/CT, including a 10 min/bed scan for the upper abdomen with a vital signal monitoring for respiratory gating (RG) followed by a 20-second BH PET/CT covering the same axial range. For the upper abdomen bed, the following PET series was reconstructed: a 2-min FB PET; RG PET (6 bins); a 20-second and 15-second BH PET (BH_15 and BH_20). Semi-quantitative analysis was performed to compare liver SUV, lesion SUV, MTV, its percentage difference and target-to-background ratio (TBR) between both BH PET and RG PET images. Subgroup analysis considered lesion location, MTV and SUV. A 5-point Likert scale was used to perform visual analysis and any missed or additional lesions were identified compared with RG PET.

Results: Quantitative analysis on overall lesions (n = 78) revealed higher SUV and TBR, and smaller MTV for both BH PET compared to FB and RG PET, with lesion location-specific variations. Neither significant difference was observed in all metrics between RG and FB PET in larger lesions, nor in MTV in lower-uptake lesions. However, both BH PET significantly enhanced these measurements. In the visual analysis, both BH PET showed noninferior performance to RG PET, and were evaluated clinically acceptable. Additional and missed lesions were observed in FB and both BH PET compared with RG PET, but didn't alter the clinical management. The BH_15 PET showed comparable performance to BH_20 PET in any comparison.

Conclusion: The BH PET/CT using [F]AlF-NOTA-LM3 is effective in detecting upper abdominal lesions, offering more accurate quantitative measurements. Using a novel PET/CT scanner, a 15-second BH PET can provide comparable and superior performance to RG PET, indicating potential feasibility in clinical routines.

References

Kang S, Moon B, Kim H, Yoon H, Kim B . The impact of data-driven respiratory gating in clinical F-18 FDG PET/CT: comparison of free breathing and deep-expiration breath-hold CT protocol. Ann Nucl Med. 2021; 35(3):328-337. DOI: 10.1007/s12149-020-01574-4. View

Hope T, Allen-Auerbach M, Bodei L, Calais J, Dahlbom M, Dunnwald L . SNMMI Procedure Standard/EANM Practice Guideline for SSTR PET: Imaging Neuroendocrine Tumors. J Nucl Med. 2023; 64(2):204-210. DOI: 10.2967/jnumed.122.264860. View

Leupe H, Ahenkorah S, Dekervel J, Unterrainer M, Van Cutsem E, Verslype C . F-Labeled Somatostatin Analogs as PET Tracers for the Somatostatin Receptor: Ready for Clinical Use. J Nucl Med. 2023; 64(6):835-841. DOI: 10.2967/jnumed.123.265622. View

Walker M, Morgan A, Bradley K, McGowan D . Data-Driven Respiratory Gating Outperforms Device-Based Gating for Clinical F-FDG PET/CT. J Nucl Med. 2020; 61(11):1678-1683. PMC: 7116324. DOI: 10.2967/jnumed.120.242248. View

Liu M, Ren C, Zhang H, Zhang Y, Huang Z, Jia R . Evaluation of the safety, biodistribution, dosimetry of [F]AlF-NOTA-LM3 and head-to-head comparison with [Ga]Ga-DOTATATE in patients with well-differentiated neuroendocrine tumors: an interim analysis of a prospective trial. Eur J Nucl Med Mol Imaging. 2024; 51(12):3719-3730. DOI: 10.1007/s00259-024-06790-y. View

Groheux D, Cochet A, Humbert O, Alberini J, Hindie E, Mankoff D . ¹⁸F-FDG PET/CT for Staging and Restaging of Breast Cancer. J Nucl Med. 2016; 57 Suppl 1:17S-26S. DOI: 10.2967/jnumed.115.157859. View

Grey N, Silosky M, Lieu C, Chin B . Current status and future of targeted peptide receptor radionuclide positron emission tomography imaging and therapy of gastroenteropancreatic-neuroendocrine tumors. World J Gastroenterol. 2022; 28(17):1768-1780. PMC: 9099199. DOI: 10.3748/wjg.v28.i17.1768. View

Hofland J, Kaltsas G, de Herder W . Advances in the Diagnosis and Management of Well-Differentiated Neuroendocrine Neoplasms. Endocr Rev. 2019; 41(2). PMC: 7080342. DOI: 10.1210/endrev/bnz004. View

Suzawa N, Ichikawa Y, Ishida M, Tomita Y, Nakayama R, Sakuma H . Respiratory-gated time-of-flight PET/CT during whole-body scan for lung lesions: feasibility in a routine clinical setting and quantitative analysis. Ann Nucl Med. 2016; 30(10):722-730. DOI: 10.1007/s12149-016-1118-3. View

10.

Cheng Z, Chen L, Wang X, Wang Y, Zhao M, Zan K . Role of breath-hold lung PET in stage IA pulmonary adenocarcinoma. Insights Imaging. 2023; 14(1):100. PMC: 10212906. DOI: 10.1186/s13244-023-01446-1. View

11.

Sigfridsson J, Lindstrom E, Iyer V, Holstensson M, Velikyan I, Sundin A . Prospective data-driven respiratory gating of [Ga]Ga-DOTATOC PET/CT. EJNMMI Res. 2021; 11(1):33. PMC: 8012445. DOI: 10.1186/s13550-021-00775-w. View

12.

Long T, Yang N, Zhou M, Chen D, Li Y, Li J . Clinical Application of 18F-AlF-NOTA-Octreotide PET/CT in Combination With 18F-FDG PET/CT for Imaging Neuroendocrine Neoplasms. Clin Nucl Med. 2019; 44(6):452-458. DOI: 10.1097/RLU.0000000000002578. View

13.

Nagamachi S, Wakamatsu H, Kiyohara S, Fujita S, Futami S, Arita H . Usefulness of a deep-inspiration breath-hold 18F-FDG PET/CT technique in diagnosing liver, bile duct, and pancreas tumors. Nucl Med Commun. 2009; 30(5):326-32. DOI: 10.1097/MNM.0b013e3283298f78. View

14.

Karp J, Surti S, Daube-Witherspoon M, Muehllehner G . Benefit of time-of-flight in PET: experimental and clinical results. J Nucl Med. 2008; 49(3):462-70. PMC: 2639717. DOI: 10.2967/jnumed.107.044834. View

15.

Nagamachi S, Wakamatsu H, Kiyohara S, Fujita S, Futami S, Arita H . The reproducibility of deep-inspiration breath-hold (18)F-FDG PET/CT technique in diagnosing various cancers affected by respiratory motion. Ann Nucl Med. 2010; 24(3):171-8. DOI: 10.1007/s12149-010-0352-3. View

16.

. EANM'23 Abstract Book Congress Sep 9-13, 2023. Eur J Nucl Med Mol Imaging. 2023; 50(Suppl 1):1-898. DOI: 10.1007/s00259-023-06333-x. View

17.

Torizuka T, Tanizaki Y, Kanno T, Futatsubashi M, Yoshikawa E, Okada H . Single 20-second acquisition of deep-inspiration breath-hold PET/CT: clinical feasibility for lung cancer. J Nucl Med. 2009; 50(10):1579-84. DOI: 10.2967/jnumed.109.064246. View

18.

van Elmpt W, Hamill J, Jones J, De Ruysscher D, Lambin P, Ollers M . Optimal gating compared to 3D and 4D PET reconstruction for characterization of lung tumours. Eur J Nucl Med Mol Imaging. 2011; 38(5):843-55. PMC: 3070073. DOI: 10.1007/s00259-010-1716-6. View

19.

Sheikhbahaei S, Verde F, Hales R, Rowe S, Solnes L . Imaging in Therapy Response Assessment and Surveillance of Lung Cancer: Evidenced-based Review With Focus on the Utility of F-FDG PET/CT. Clin Lung Cancer. 2020; 21(6):485-497. DOI: 10.1016/j.cllc.2020.06.020. View

20.

Guerra L, De Ponti E, Elisei F, Bettinardi V, Landoni C, Picchio M . Respiratory gated PET/CT in a European multicentre retrospective study: added diagnostic value in detection and characterization of lung lesions. Eur J Nucl Med Mol Imaging. 2012; 39(9):1381-90. DOI: 10.1007/s00259-012-2148-2. View